Eureka Forbes Ltd
Eureka Forbes Ltd
Consumer GoodsKey Fundamentals
MicrocapHousehold AppliancesConsumer GoodsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Eureka Forbes Ltd insights
44 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has delivered good profit growth of 160% CAGR over last 5 years
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 3.46% over last 3 years.
- Promoters have pledged 53.7% of their holding.
- Promoter holding has decreased over last 3 years: -10.0%
Growth Rate
AI Analysis — Bull vs Bear
Eureka Forbes Ltd trades at a market cap of ₹8,685 Cr with a PE of 53.5x and near-zero debt. The company has shown strong profit growth (160% CAGR over 5 years) but generates a low return on equity of ~3.5% over 3 years, while promoters have pledged 53.7% of their holding.
- Company is almost debt free, providing financial flexibility and low interest burden
- Compounded profit growth of 160% CAGR over 5 years indicates rapid earnings expansion from a low base
- TTM sales growth of 11% shows continued revenue momentum in the consumer goods segment
- TTM profit growth of 23% outpaces sales growth, suggesting improving operating leverage
- 3-year compounded profit CAGR of 89% demonstrates sustained earnings recovery trajectory
- ROE improved to 4% in the last year from a 3-year average of 3%, indicating gradual profitability improvement
- Price-to-book ratio of 1.89x is relatively moderate for a consumer brand franchise
- Promoters have pledged 53.7% of their holding, creating significant overhang and forced-selling risk
- Promoter holding has decreased by 10% over the last 3 years, signaling potential lack of confidence
- PE of 53.5x is elevated given the low ROE of 3.46% over 3 years, implying the stock prices in substantial future improvement
- 3-year ROE of only 3% and 10-year ROE of 2% indicate structurally poor capital efficiency
- Zero dividend payout despite reporting repeated profits, offering no income return to shareholders
- Stock price CAGR of -19% over 1 year and -6% over 3 years shows persistent market underperformance
- 5-year compounded sales CAGR of 222% is likely distorted by corporate restructuring rather than organic growth
- Market cap of ₹8,685 Cr on thin profitability metrics raises valuation sustainability concerns
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Major promoter share pledge Jul 31
Lunolux Limited pledged an additional 11.4M Eureka Forbes shares due to collateral shortfall, raising total encumbrance to 39.47% of holdings. High promoter pledging increases risk of forced selling if share price declines.
- AGM scheduled for Aug 19 Jul 20
Eureka Forbes will hold its 17th AGM on August 19, 2026 via video conferencing at 12:00 Noon IST. Routine corporate governance event with no unusual agenda flagged.
TL;DR: Eureka Forbes faces elevated promoter pledging risk with nearly 40% of Lunolux's stake now encumbered due to a collateral shortfall, which signals financial stress at the promoter level. No operational positives or growth catalysts emerged in recent news flow. The AGM on Aug 19 may provide more clarity on business direction. The trend is cautious given rising pledge levels without offsetting positive developments.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 505 | 592 | 539 | 553 | 553 | 673 | 598 | 613 | 608 | 773 | 645 | 684 | 701 |
| Expenses | 459 | 541 | 496 | 500 | 498 | 601 | 539 | 535 | 546 | 678 | 578 | 599 | 633 |
| Operating Profit | 46 | 51 | 42 | 53 | 55 | 72 | 59 | 78 | 61 | 96 | 67 | 85 | 67 |
| OPM % | 9% | 9% | 8% | 10% | 10% | 11% | 10% | 13% | 10% | 12% | 10% | 12% | 10% |
| Other Income | 2 | 2 | 3 | -13 | 2 | 6 | 4 | 6 | 7 | 6 | -35 | 5 | 27 |
| Interest | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 2 | 1 |
| Depreciation | 13 | 13 | 13 | 14 | 14 | 14 | 15 | 15 | 16 | 16 | 17 | 20 | 19 |
| PBT | 31 | 37 | 30 | 24 | 42 | 62 | 47 | 68 | 52 | 83 | 12 | 68 | 74 |
| Tax % | 29% | 31% | 25% | 12% | 25% | 25% | 26% | 25% | 25% | 26% | 27% | 25% | 26% |
| Net Profit | 22 | 25 | 23 | 21 | 31 | 47 | 35 | 51 | 39 | 62 | 9 | 51 | 55 |
| EPS in Rs | 1.14 | 1.32 | 1.17 | 1.11 | 1.61 | 2.41 | 1.8 | 2.62 | 1.99 | 3.18 | 0.47 | 2.64 | 2.87 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 28 | 33 | 27 | 26 | 16 | 8 | 381 | 2,080 | 2,189 | 2,436 | 2,710 | 2,804 |
| Expenses | 0 | 28 | 32 | 27 | 26 | 16 | 9 | 363 | 1,949 | 1,997 | 2,173 | 2,400 | 2,488 |
| Operating Profit | 0 | 1 | 2 | -1 | 0 | 0 | -1 | 18 | 132 | 192 | 263 | 310 | 316 |
| OPM % | — | 2.2% | 4.7% | -3.1% | -1.2% | -0.5% | -17% | 4.7% | 6% | 9% | 11% | 11% | 11% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | -30 | -7 | 19 | -18 | 2 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 | 20 | 10 | 6 | 8 | 8 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 55 | 53 | 58 | 69 | 72 |
| PBT | 0 | 0 | 1 | -1 | -1 | -1 | -2 | 7 | 27 | 122 | 219 | 216 | 238 |
| Tax % | — | -8% | 8% | 9% | -9% | 56% | 1% | 59% | 37% | 25% | 25% | 26% | — |
| Net Profit | 0 | 0 | 1 | -1 | -1 | -1 | -2 | 3 | 17 | 92 | 163 | 160 | 177 |
| EPS in Rs | 0 | 0.5 | 2.62 | -4.7 | -2.48 | -1.84 | -3.38 | 0.14 | 0.88 | 4.73 | 8.44 | 8.28 | 9.16 |
| Div. Payout % | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 3 | 3 | 3 | 3 | 5 | 5 | 193 | 193 | 193 | 193 | 193 |
| Reserves | 0 | -1 | 0 | -2 | -2 | -3 | -5 | 3,874 | 3,886 | 4,010 | 4,191 | 4,380 |
| Borrowings | 0 | 4 | 4 | 4 | 4 | 2 | 2 | 253 | 139 | 39 | 26 | 29 |
| Other Liabilities | 0 | 12 | 12 | 9 | 9 | 7 | 5 | 1,815 | 1,810 | 1,878 | 1,899 | 2,100 |
| Total Liabilities | 0 | 18 | 18 | 14 | 14 | 10 | 7 | 6,135 | 6,029 | 6,120 | 6,310 | 6,702 |
| Fixed Assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5,498 | 5,475 | 5,457 | 5,466 | 5,504 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 7 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87 | 101 | 80 | 84 | 88 |
| Other Assets | 0 | 17 | 18 | 14 | 14 | 10 | 7 | 550 | 451 | 582 | 758 | 1,103 |
| Total Assets | 0 | 18 | 18 | 14 | 14 | 10 | 7 | 6,135 | 6,029 | 6,120 | 6,310 | 6,702 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | — | — | — | — | 1 | 0 | 37 | 171 | 195 | 226 | 242 |
| Investing | — | — | — | — | — | 0 | 0 | 7 | -22 | -35 | -168 | -175 |
| Financing | — | — | — | — | — | -1 | 0 | -31 | -150 | -117 | -43 | -22 |
| Net Cash Flow | — | — | — | — | — | -1 | 0 | 13 | -1 | 43 | 14 | 45 |
| Free Cash Flow | — | — | — | — | — | 1 | 0 | 33 | 160 | 169 | 170 | 157 |
| CFO/OP | — | — | — | — | — | -1,200 | 11 | 212 | 133 | 101 | 83 | 78 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | 156 | 141 | 107 | 110 | 63 | 110 | 147 | 22 | 23 | 27 | 31 |
| Inventory Days | — | 34 | 21 | 37 | 33 | 90 | 109 | 638 | 91 | 99 | 90 | 119 |
| Days Payable | — | 164 | 153 | 137 | 143 | 159 | 256 | 549 | 99 | 89 | 69 | 75 |
| Cash Conversion Cycle | — | 26 | 10 | 7 | 1 | -7 | -37 | 235 | 14 | 33 | 48 | 76 |
| Working Capital Days | — | 37 | 34 | 31 | -48 | -33 | -105 | -546 | -103 | -87 | -71 | -54 |
| ROCE % | — | 20% | 24% | -12% | -5% | -4% | -58% | 0% | 2% | 3% | 5% | 6% |
Documents
Frequently Asked Questions about Eureka Forbes Ltd
What does Eureka Forbes Ltd do?
Where is Eureka Forbes Ltd (EUREKAFORB) listed?
Which sector does Eureka Forbes Ltd belong to?
What is the market capitalisation of Eureka Forbes Ltd?
What is the PE ratio of Eureka Forbes Ltd?
What is the 52-week high and low of Eureka Forbes Ltd?
What is the Return on Equity (ROE) of Eureka Forbes Ltd?
How can I research Eureka Forbes Ltd on Tapetide?
Company Information
Eureka Forbes Limited is India’s leading health and hygiene brand. Its product portfolio encompasses water purification, vacuum cleaning and air purification.[1]